why choose us

First received: June 26, 2023

Clinical Trial: A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lymphoma

Study Type: INTERVENTIONAL


Official Title: A Phase II Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma

Brief Summary: To learn if response-adapted, ultra-low dose radiation therapy can help to control MZL.This means participates first receive lower does of radiation therapy and then, based on how the disease responds, may receive higher doses after that.

Read more